Treating diabetic retinopathy (DR ... the many who do not respond to current treatments. Pre-clinical results for its leading drug NG004, show a new mode of action and NovaGo plans to move ...

“I think some of the new treatments will probably move the needle a little bit more in terms of treating this indication.” Ip MS. Update on the current treatment of diabetic retinopath ...

The collaboration will focus on preventive solutions, workshops, and public awareness. King Faisal Specialist Hospital and ...

The phase 1 clinical trial is a multicenter, open-label, dose-escalation study to assess drug safety via intravitreal ...

AbbVie (NYSE: ABBV) and REGENXBIO Inc. (Nasdaq: RGNX) today announced updates to the ABBV-RGX-314 clinical program.

“There’s very clear evidence that screening prevents vision loss,” says Roomasa Channa, a retina specialist at the University of Wisconsin-Madison in the US. In the US barriers include cost, ...

The implementation of AIDRSS offers transformative implications for DR screening in India, particularly in rural and ...

DR was graded according to early Treatment Diabetic Retinopathy (ETDRS) criteria. Results: Of 199 subjects, 108 patients (54.3%) suffer from dry eye syndrome. Although dry eye syndrome was more ...